Evidence map›Paper›PMID 27145942›Full record

ArticleChinese journal of integrative medicine2017

Protective effects of traditional Tibetan medicine Zuo-Mu-A Decoction () on the blood parameters and myocardium of high altitude polycythemia model rats.

Meng-Qian Lu, Nyima Tsring, Tian-Yuan Yu, Jian-Cong Wu, Steven Wong, Guo-Yong Chen, Pasang Dekyi, Fan Pan, Si-Tong Xian, Dorje Rinchen and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Chinese journal of integrative medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Metabonomics window into plateau hypoxia.The Journal of international medical research · 2019
    Review
  5. Phenotype-Specific Therapeutic Effect ofInternational journal of molecular sciences · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Meng-Qian LuSchool of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, 100029, China.
Nyima TsringTibetan Traditional Medical College, Lhasa, 850000, China. bairizerendawa@163.com.
Tian-Yuan YuSchool of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, 100029, China. yutianyuan@sina.com.
Jian-Cong WuDepartment of Tuina, Beijing Massage Hospital, Beijing, 100035, China.
Steven WongSchool of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, 100029, China.
Guo-Yong ChenInformation Center, Beijing University of Chinese Medicine, Beijing, 100029, China.
Pasang DekyiTibet Academy of Tibetan Medicine, Lhasa, 850000, China.
Fan PanSchool of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, 100029, China.
Si-Tong XianSchool of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, 100029, China.
Dorje RinchenTibetan Traditional Medical College, Lhasa, 850000, China.
Ying-Qiu MaoCenter of Scientific Experiment, Beijing University of Chinese Medicine, Beijing, 100029, China.
Lin-Feng ZhangSchool of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, 100029, China.
Bin-Bin YaoSchool of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, 100029, China.
Beijing University of Chinese Medicine · CNTibetan Traditional Medical College · CNBeijing Hospital of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo explore the protective effects of Tibetan medicine Zuo-Mu-A Decoction (, ZMAD) on the blood parameters and myocardium of high altitude polycythemia (HAPC) model rats.

methodsForty male Wistar rats were randomly divided into 4 groups by a random number table, including the normal, model, Rhodiola rosea L. (RRL) and ZMAD groups (10 in each group). Every group was raised in Lhasa to create a HAPC model except the normal group. After modeling, rats in the RRL and the ZMAD groups were administered intragastrically with RRL (20 mL/kg) and ZMAD (7.5 mL/kg) once a day for 2 months, respectively; for the normal and the model groups, 5 mL of distilled water was administered intragastrically instead of decoction. Then routine blood and hematologic rheology parameters were taken, levels of erythropoietin and 8-hydroxy-2'-deoxyguanosine (8-OHdG) were tested, and ultrastructural change in the left ventricular myocardium was observed using transmission electron microscopy.

resultsCompared with the model group, ZMAD significantly reduced the red blood cell count, hemoglobin levels, whole blood viscosity at low/middle shear rates, plasma viscosity, erythrocyte electrophoretic time, erythropoietin and 8-OHdG levels, and also increased the erythrocyte deformation index (P<0.05). There was no difference in all results between the RRL and the ZMAD groups. The cardiac muscle fibers were well-protected, mitochondrial matrix swelled mildly and ultrastructure changes were less prominent in the ZMAD group compared with the model group.

conclusionZMAD has significant protective effects on the blood parameters against HAPC, and also has the beneficial effect in protecting against myocardial injury.

Indexed as

Medicine, Tibetan Traditional8-Hydroxy-2'-DeoxyguanosineAltitude SicknessAnimalsDeoxyguanosineDisease Models, AnimalErythropoietinMyocardiumPolycythemiaProtective AgentsRheology8-Hydroxy-2'-DeoxyguanosineDeoxyguanosineErythropoietinProtective Agentserythropoietinhematologyhigh altitude polycythemiamyocardiumtraditional medicine

Identifiers

PMID27145942
OpenAlexW2345662606

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.